Home » Medical Devices » Peripheral Vascular Stents Market

Peripheral Vascular Stents Market By Type (Drug Eluting Stents [DES], Bare Metal Stents [BMS], Bioabsorbable Stents); By Product (Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, Other Peripheral Stents); By End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Name: Peripheral Vascular Stents Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2025-10-24
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Peripheral Vascular Stents Market

Summary
Table Of Content
Request Free Sample

Market Overview:

Peripheral Vascular Stents Market size was valued at USD 2,812.6 Million in 2018 and reached USD 3,920.3 Million in 2024. It is anticipated to grow to USD 6,166.3 Million by 2032, at a CAGR of 5.85% during the forecast period.

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Peripheral Vascular Stents Market Size 2024	USD 3,920.3 Million
Peripheral Vascular Stents Market, CAGR	5.85%
Peripheral Vascular Stents Market Size 2032	USD 6,166.3 Million

The Peripheral Vascular Stents Market is highly competitive, led by key players such as Medtronic, Terumo Corporation, Boston Scientific Inc., Stryker, Biotronik, Cook, Microport Scientific Corporation, iVascular SLU, Stentys S.A., BD, and B. Braun. These companies focus on product innovation, strategic partnerships, and regional expansion to strengthen their market presence. Continuous advancements in drug-eluting and bioabsorbable stents, coupled with next-generation stent technologies, drive adoption across hospitals, cardiac centers, and ambulatory surgical facilities. North America is the leading region in this market, holding a 30% share in 2024, supported by advanced healthcare infrastructure, high prevalence of peripheral artery disease, and robust adoption of minimally invasive procedures. The dominance of established players and strong regional demand fosters ongoing innovation, competitive pricing strategies, and expanded market penetration, reinforcing North America’s leadership position in the global Peripheral Vascular Stents Market.

Peripheral Vascular Stents Market sizr

Market Insights

The Peripheral Vascular Stents Market was valued at USD 3,920.3 Million in 2024 and is projected to reach USD 6,166.3 Million by 2032, growing at a CAGR of 5.85%. North America holds the largest regional share of 30%, followed by Europe at 27% and Asia Pacific at 24%.
Market growth is driven by rising prevalence of peripheral artery disease, increasing cases of diabetes and hypertension, and growing adoption of minimally invasive endovascular procedures.
Technological advancements in stents, including drug-eluting and bioabsorbable variants, along with next-generation designs, are creating opportunities for improved clinical outcomes and higher adoption rates.
The market is competitive, with major players such as Medtronic, Terumo Corporation, Boston Scientific Inc., Stryker, Biotronik, and B. Braun investing in R&D, partnerships, and product launches to maintain market leadership.
Market restraints include the high cost of advanced stents and risks of post-operative complications, while regional growth is supported by expanding healthcare infrastructure in emerging markets like Asia Pacific and Latin America.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Segmentation Analysis:

By Type

The Drug Eluting Stents (DES) segment dominates the Peripheral Vascular Stents Market, capturing 55% of the type segment share in 2024. The growth of DES is driven by their ability to reduce restenosis and improve long-term patient outcomes, making them preferred in complex peripheral artery interventions. Bare Metal Stents (BMS) hold around 30% of the market, while Bioabsorbable Stents account for 15%, gaining traction due to advancements in biodegradable materials and minimally invasive procedures. Rising cardiovascular disease prevalence and increasing adoption of interventional cardiology procedures fuel the overall market growth.

For instance, Abbott’s launch of the XIENCE Sierra Everolimus-eluting stent system in 2024 highlights advancements in drug-eluting technology, providing enhanced treatment options for blocked coronary arteries.

By Product

Within the product segment, Femoral Artery Stents lead with 40% of the product market share, owing to the high incidence of peripheral arterial disease in the lower limbs. Iliac Artery Stents follow with 25%, while Carotid Artery Stents and Renal Artery Stents hold 20% and 10% respectively. The Other Peripheral Stents category contributes 5%. Demand is primarily driven by the increasing number of endovascular interventions, advancements in stent design, and rising awareness of minimally invasive therapies, particularly in aging populations prone to peripheral vascular disorders.

For instance, Boston Scientific’s Express™ LD Iliac Stent demonstrated a 97.2% stent patency rate at 1 year and 94.1% at 2 years in the MELODIE clinical trial, underscoring its efficacy in treating atherosclerotic iliac lesions.

By End User

The Hospitals & Cardiac Centers segment dominates with 65% of the end-user market share, supported by their infrastructure, availability of skilled interventional cardiologists, and capacity to perform complex stent procedures. Ambulatory Surgical Centers represent 25%, benefiting from cost-effective outpatient procedures and faster patient turnaround. The Others segment, including specialized clinics and research facilities, holds 10%. Market growth is driven by the increasing number of hospital admissions for peripheral artery disease, government healthcare initiatives, and rising patient preference for hospital-based interventions that ensure procedural safety and comprehensive post-operative care.

Key Growth Drivers

Rising Prevalence of Peripheral Artery Disease

The increasing incidence of peripheral artery disease (PAD) globally is a major growth driver for the Peripheral Vascular Stents Market. Factors such as diabetes, hypertension, and obesity contribute to arterial blockages, raising the demand for stent-based interventions. Hospitals and cardiac centers are seeing a surge in patients requiring drug-eluting and bioabsorbable stents. Early diagnosis, awareness campaigns, and advancements in interventional cardiology further propel adoption, particularly in developed regions where aging populations are more susceptible to vascular complications.

For instance, the EMINENT randomized trial demonstrated that paclitaxel-eluting stents significantly improved primary patency rates at one year for patients with femoropopliteal PAD, boosting their adoption in clinical settings.

Technological Advancements in Stents

Continuous innovation in stent materials and design is fueling market growth. Drug-eluting stents with enhanced anti-restenosis properties, bioabsorbable stents with biodegradable polymers, and advanced coatings improve procedural safety and patient outcomes. These technological developments reduce complications and expand treatable vascular conditions. R&D investments and the introduction of patient-specific stents are driving adoption across hospitals and ambulatory surgical centers, strengthening the market position of manufacturers and enhancing their competitive edge globally.

For instance, bioabsorbable stents like the Abbott BVS by Abbott Vascular employ biodegradable polymers that provide vessel support initially and then dissolve over six months, leaving the vessel free of permanent implants to reduce long-term complications.

Increasing Adoption of Minimally Invasive Procedures

The rising preference for minimally invasive endovascular procedures is accelerating the market. Such procedures reduce hospitalization duration, lower surgical risks, and enhance patient recovery, making them widely preferred by both physicians and patients. Outpatient interventions and cost-effective treatment options further boost adoption in hospitals and cardiac centers. Improved procedural efficiency, patient comfort, and favorable clinical outcomes position minimally invasive stenting as a critical growth driver for the global peripheral vascular stents market.

Key Trends & Opportunities

Expansion in Emerging Markets

Emerging markets in Asia Pacific, Latin America, and the Middle East present significant growth opportunities. Growing healthcare infrastructure, higher disposable incomes, and increased access to advanced cardiovascular treatments are driving stent adoption. Manufacturers are targeting these regions through partnerships, acquisitions, and localized production. Countries like India, China, and Brazil, with a rising prevalence of cardiovascular diseases, represent untapped potential, enabling both hospitals and stent providers to expand market reach and establish strong regional presence.

For instance, in Brazil, Chinese medical teams from Xiamen Cardiovascular Hospital successfully introduced VenusA-Pro, a domestically developed reusable valve intervention device, in public healthcare, marking China’s first implantation of this device there.

Development of Next-Generation Stents

Next-generation stents, including bioabsorbable and drug-eluting variants, are creating strong market opportunities. These stents lower the risk of restenosis, improve long-term patient outcomes, and are increasingly preferred for complex procedures. Continuous innovation in materials, coatings, and delivery mechanisms enhances procedural success rates. Market players investing in R&D and launching advanced stent products can capitalize on rising demand, particularly in developed regions, where hospitals and cardiac centers prioritize high-efficacy, technologically advanced solutions.

For instance, Medtronic’s Onyx Frontier drug-eluting stent features an enhanced delivery system that improves deliverability by 16% compared to its predecessor, supporting complex cases with a broad size range suitable for large vessels like the left main artery.

Key Challenges

High Cost of Advanced Stents

The elevated cost of advanced stents, particularly drug-eluting and bioabsorbable variants, limits accessibility in price-sensitive regions. High procurement and procedural expenses restrict adoption in emerging markets, where healthcare budgets are constrained. Cost barriers also affect ambulatory surgical centers and smaller hospitals that cannot invest in premium stent technologies. Manufacturers face pressure to optimize production costs and provide affordable options without compromising quality, while healthcare providers seek reimbursement strategies to increase patient access and expand the market footprint.

Risk of Post-Operative Complications

Despite technological advancements, post-operative complications such as stent thrombosis, restenosis, or migration remain key challenges. Patient comorbidities, procedural errors, and improper stent selection can lead to adverse outcomes, impacting market perception and adoption. Hospitals and cardiac centers require extensive training, strict procedural protocols, and post-operative monitoring to mitigate risks. Manufacturers must focus on improving stent safety, efficacy, and guidance systems while providing physician education to minimize complications and enhance overall market confidence.

Regional Analysis

North America

North America dominates the Peripheral Vascular Stents Market, with a market size of USD 849.69 million in 2018, reaching USD 1,163.99 million in 2024 and projected to grow to USD 1,788.22 million by 2032, at a CAGR of 5.5%. The region holds 30% of the global market share, driven by well-established healthcare infrastructure, increasing prevalence of peripheral artery disease, and widespread adoption of drug-eluting and bioabsorbable stents. The U.S. leads the market due to high healthcare expenditure, advanced interventional cardiology facilities, and robust research and development activities supporting technological innovation.

Europe

Europe accounted for a market size of USD 771.50 million in 2018, increasing to USD 1,078.53 million in 2024 and expected to reach USD 1,703.13 million by 2032, growing at a CAGR of 5.9%. The region represents 27% of the global market share. Growth is fueled by aging populations, rising incidence of cardiovascular disorders, and advanced hospital networks. Key countries such as Germany, France, and the UK lead in stent adoption due to technological advancements, strong reimbursement policies, and increasing awareness of minimally invasive procedures among patients and healthcare providers.

Asia Pacific

Asia Pacific’s market was valued at USD 675.31 million in 2018, projected to reach USD 958.06 million in 2024 and USD 1,542.19 million by 2032, at a CAGR of 6.2%. The region holds 24% of the global market share, driven by expanding healthcare infrastructure, growing awareness of peripheral artery disease, and increased adoption of advanced stents. Countries like China, Japan, and India are witnessing significant demand due to rising cardiovascular disease prevalence, higher patient affordability, and initiatives promoting minimally invasive procedures, making the region a key growth opportunity for global market players.

Latin America

Latin America’s Peripheral Vascular Stents Market was valued at USD 309.95 million in 2018, expected to grow to USD 435.54 million in 2024 and USD 692.47 million by 2032, with a CAGR of 6.0%. The region accounts for roughly 8% of global market share, supported by improving healthcare infrastructure, rising cardiovascular disease cases, and increasing accessibility to interventional cardiology procedures. Brazil and Argentina lead adoption due to expanding hospital networks and awareness programs. Strategic collaborations and localized product launches by market players further enhance market penetration across Latin American countries.

Middle East

The Middle East market stood at USD 134.44 million in 2018, reaching USD 192.09 million in 2024 and anticipated to hit USD 312.01 million by 2032, at a CAGR of 6.3%. Representing about 5% of the global market share, growth is driven by rising cardiovascular disease prevalence, expanding healthcare infrastructure, and increased adoption of minimally invasive procedures. GCC countries, Israel, and Turkey are the primary contributors, supported by government healthcare initiatives and investments in advanced medical technologies, while growing patient awareness further fuels demand for peripheral vascular stents.

Africa

Africa accounted for a market size of USD 71.72 million in 2018, expected to grow to USD 92.07 million in 2024 and USD 128.26 million by 2032, at a CAGR of 4.2%. The region holds 3% of the global market share, constrained by limited healthcare infrastructure and low awareness of minimally invasive interventions. South Africa and Egypt are the leading contributors, driven by improving hospital facilities, increasing incidence of cardiovascular diseases, and gradual adoption of advanced stent technologies. Investments in healthcare modernization and training programs are expected to support incremental market growth.

Market Segmentations:

By Type

Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents

By Product

Iliac Artery Stents
Femoral Artery Stents
Carotid Artery Stents
Renal Artery Stents
Other Peripheral Stents

By End User

Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Competitive Landscape

The competitive landscape of the Peripheral Vascular Stents Market features major players including Medtronic, Terumo Corporation, Boston Scientific Inc., Stryker, Biotronik, Cook, Microport Scientific Corporation, iVascular SLU, Stentys S.A., BD, and B. Braun. These companies focus on strategic initiatives such as product innovation, mergers and acquisitions, partnerships, and geographic expansion to strengthen their market presence. Competition is driven by technological advancements in drug-eluting and bioabsorbable stents, as well as the launch of next-generation stents with improved clinical outcomes. Companies invest heavily in R&D to develop precision stents and enhance procedural efficiency, catering to hospitals, cardiac centers, and ambulatory surgical facilities. Pricing strategies, regulatory compliance, and customer support also play critical roles in maintaining market share. The presence of multiple global and regional players fosters innovation, drives adoption of advanced stent technologies, and intensifies competition across all regions.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Medtronic
Terumo Corporation
Boston Scientific Inc.
Stryker
Biotronik
Cook
Microport Scientific Corporation
iVascular SLU
Stentys S.A.
BD
Braun
Other Key Players

Recent Developments

In October 2025, Medtronic launched the Neuroguard IEP™ System, a 3-in-1 carotid artery stent integrating a high-performance stent, dilation balloon, and embolic protection filter to enhance procedural efficiency in carotid artery interventions.
In May 2025, Terumo Interventional Systems launched the ROADSAVER Stent System, the first dual-layer micromesh carotid artery stent approved in the U.S., designed to contain plaque and prevent distal embolization.
In September 2024, Boston Scientific completed the acquisition of Silk Road Medical for $1.26 billion, strengthening its carotid artery disease portfolio, particularly with the TCAR platform.
In December 2024, Terumo Interventional Systems introduced the R2P NaviCross Peripheral Support Catheter, designed to optimize performance in radial-to-peripheral procedures and expand its R2P product portfolio.

Report Coverage

The research report offers an in-depth analysis based on Type, Product, End User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Peripheral Vascular Stents Market is expected to grow steadily, driven by rising cardiovascular disease prevalence.
Adoption of drug-eluting and bioabsorbable stents will increase due to improved patient outcomes.
Minimally invasive procedures will continue to gain popularity, boosting stent demand across hospitals and cardiac centers.
Technological advancements in stent design and materials will create new growth opportunities.
Emerging markets in Asia Pacific, Latin America, and the Middle East will witness significant market expansion.
Hospitals and cardiac centers will remain the dominant end users, with ambulatory surgical centers gradually increasing adoption.
Next-generation stents with enhanced safety and precision will drive higher market penetration.
Strategic collaborations, partnerships, and product launches will strengthen the competitive landscape.
Government initiatives and awareness programs for peripheral artery disease will support market growth.
Overall, the market will evolve with innovative solutions and increasing regional accessibility of advanced stent technologies.

CHAPTER NO. 1 : GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2 : EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3 : PERIPHERAL VASCULAR STENTS MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

CHAPTER NO. 4 : KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Type Categories

4.3 End User Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Type, Product, and End User Revenue

CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS

6.1. Import Analysis By Region

6.1.1. Global Peripheral Vascular Stents Market Import Revenue By Region

6.2. Export Analysis By Region

6.2.1. Global Peripheral Vascular Stents Market Export Revenue By Region

CHAPTER NO. 7 : COMPETITION ANALYSIS

7.1. Company Market Share Analysis

7.1.1. Global Peripheral Vascular Stents Market: Company Market Share

7.2. Global Peripheral Vascular Stents Market Company Revenue Market Share

7.3. Strategic Developments

7.3.1. Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8 : PERIPHERAL VASCULAR STENTS MARKET – BY TYPE SEGMENT ANALYSIS

8.1. Peripheral Vascular Stents Market Overview By Type Segment

8.1.1. Peripheral Vascular Stents Market Revenue Share By Type

8.2. Drug Eluting Stents (DES)

8.3. Bare Metal Stents (BMS)

8.4. Bioabsorbable Stents

CHAPTER NO. 9 : PERIPHERAL VASCULAR STENTS MARKET – BY PRODUCT SEGMENT ANALYSIS

9.1. Peripheral Vascular Stents Market Overview By Product Segment

9.1.1. Peripheral Vascular Stents Market Revenue Share By Product

9.2. Iliac Artery Stents

9.3. Femoral Artery Stents

9.4. Carotid Artery Stents

9.5. Renal Artery Stents

9.6. Other Peripheral Stents

CHAPTER NO. 10 : PERIPHERAL VASCULAR STENTS MARKET – BY END USER SEGMENT ANALYSIS

10.1. Peripheral Vascular Stents Market Overview By End User Segment

10.1.1. Peripheral Vascular Stents Market Revenue Share By End User

10.2. Hospitals & Cardiac Centers

10.3. Ambulatory Surgical Centers

10.4. Others

CHAPTER NO. 11 : PERIPHERAL VASCULAR STENTS MARKET – REGIONAL ANALYSIS

11.1. Peripheral Vascular Stents Market Overview By Region Segment

11.1.1. Global Peripheral Vascular Stents Market Revenue Share By Region

10.1.2. Regions

11.1.3. Global Peripheral Vascular Stents Market Revenue By Region

11.1.4. Type

11.1.5. Global Peripheral Vascular Stents Market Revenue By Type

11.1.6. Product

11.1.7. Global Peripheral Vascular Stents Market Revenue By Product

11.1.8. End User

11.1.9. Global Peripheral Vascular Stents Market Revenue By End User

CHAPTER NO. 12 : NORTH AMERICA PERIPHERAL VASCULAR STENTS MARKET – COUNTRY ANALYSIS

12.1. North America Peripheral Vascular Stents Market Overview By Country Segment

12.1.1. North America Peripheral Vascular Stents Market Revenue Share By Region

12.2. North America

12.2.1. North America Peripheral Vascular Stents Market Revenue By Country

12.2.2. Type

12.2.3. North America Peripheral Vascular Stents Market Revenue By Type

12.2.4. Product

12.2.5. North America Peripheral Vascular Stents Market Revenue By Product

12.2.6. End User

12.2.7. North America Peripheral Vascular Stents Market Revenue By End User

12.3. U.S.

12.4. Canada

12.5. Mexico

CHAPTER NO. 13 : EUROPE PERIPHERAL VASCULAR STENTS MARKET – COUNTRY ANALYSIS

13.1. Europe Peripheral Vascular Stents Market Overview By Country Segment

13.1.1. Europe Peripheral Vascular Stents Market Revenue Share By Region

13.2. Europe

13.2.1. Europe Peripheral Vascular Stents Market Revenue By Country

13.2.2. Type

13.2.3. Europe Peripheral Vascular Stents Market Revenue By Type

13.2.4. Product

13.2.5. Europe Peripheral Vascular Stents Market Revenue By Product

13.2.6. End User

13.2.7. Europe Peripheral Vascular Stents Market Revenue By End User

13.3. UK

13.4. France

13.5. Germany

13.6. Italy

13.7. Spain

13.8. Russia

13.9. Rest of Europe

CHAPTER NO. 14 : ASIA PACIFIC PERIPHERAL VASCULAR STENTS MARKET – COUNTRY ANALYSIS

14.1. Asia Pacific Peripheral Vascular Stents Market Overview By Country Segment

14.1.1. Asia Pacific Peripheral Vascular Stents Market Revenue Share By Region

14.2. Asia Pacific

14.2.1. Asia Pacific Peripheral Vascular Stents Market Revenue By Country

14.2.2. Type

14.2.3. Asia Pacific Peripheral Vascular Stents Market Revenue By Type

14.2.4. Product

14.2.5. Asia Pacific Peripheral Vascular Stents Market Revenue By Product

14.2.6. End User

14.2.7. Asia Pacific Peripheral Vascular Stents Market Revenue By End User

14.3. China

14.4. Japan

14.5. South Korea

14.6. India

14.7. Australia

14.8. Southeast Asia

14.9. Rest of Asia Pacific

CHAPTER NO. 15 : LATIN AMERICA PERIPHERAL VASCULAR STENTS MARKET – COUNTRY ANALYSIS

15.1. Latin America Peripheral Vascular Stents Market Overview By Country Segment

15.1.1. Latin America Peripheral Vascular Stents Market Revenue Share By Region

15.2. Latin America

15.2.1. Latin America Peripheral Vascular Stents Market Revenue By Country

15.2.2. Type

15.2.3. Latin America Peripheral Vascular Stents Market Revenue By Type

15.2.4. Product

15.2.5. Latin America Peripheral Vascular Stents Market Revenue By Product

15.2.6. End User

15.2.7. Latin America Peripheral Vascular Stents Market Revenue By End User

15.3. Brazil

15.4. Argentina

15.5. Rest of Latin America

CHAPTER NO. 16 : MIDDLE EAST PERIPHERAL VASCULAR STENTS MARKET – COUNTRY ANALYSIS

16.1. Middle East Peripheral Vascular Stents Market Overview By Country Segment

16.1.1. Middle East Peripheral Vascular Stents Market Revenue Share By Region

16.2. Middle East

16.2.1. Middle East Peripheral Vascular Stents Market Revenue By Country

16.2.2. Type

16.2.3. Middle East Peripheral Vascular Stents Market Revenue By Type

16.2.4. Product

16.2.5. Middle East Peripheral Vascular Stents Market Revenue By Product

16.2.6. End User

16.2.7. Middle East Peripheral Vascular Stents Market Revenue By End User

16.3. GCC Countries

16.4. Israel

16.5. Turkey

16.6. Rest of Middle East

CHAPTER NO. 17 : AFRICA PERIPHERAL VASCULAR STENTS MARKET – COUNTRY ANALYSIS

17.1. Africa Peripheral Vascular Stents Market Overview By Country Segment

17.1.1. Africa Peripheral Vascular Stents Market Revenue Share By Region

17.2. Africa

17.2.1. Africa Peripheral Vascular Stents Market Revenue By Country

17.2.2. Type

17.2.3. Africa Peripheral Vascular Stents Market Revenue By Type

17.2.4. Product

17.2.5. Africa Peripheral Vascular Stents Market Revenue By Product

17.2.6. End User

17.2.7. Africa Peripheral Vascular Stents Market Revenue By End User

17.3. South Africa

17.4. Egypt

17.5. Rest of Africa

CHAPTER NO. 18 : COMPANY PROFILES

18.1. Medtronic

18.1.1. Company Overview

18.1.2. Product Portfolio

18.1.3. Financial Overview

18.1.4. Recent Developments

18.1.5. Growth Strategy

18.1.6. SWOT Analysis

18.2. Terumo Corporation

18.3. Boston Scientific Inc.

18.4. Stryker

18.5. Biotronik

18.6. Cook

18.6. Microport Scientific Corporation

18.7. iVascular SLU

18.8. Stentys S.A.

18.9. BD

18.10. B. Braun

18.11. Other Key Players

Request A Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Question:

What is the current market size for Peripheral Vascular Stents Market, and what is its projected size in 2032?

The Peripheral Vascular Stents Market is valued at USD 3,920.3 Million in 2024 and is projected to reach USD 6,166.3 Million by 2032.

At what Compound Annual Growth Rate is the Peripheral Vascular Stents Market projected to grow between 2025 and 2032?

The Peripheral Vascular Stents Market is expected to grow at a CAGR of 5.85% during the forecast period.

Which Peripheral Vascular Stents Market segment held the largest share in 2024?

The Drug Eluting Stents (DES) segment held the largest share, capturing 55% of the type segment in 2024.

What are the primary factors fueling the growth of the Peripheral Vascular Stents Market?

Growth is driven by rising cardiovascular disease prevalence, technological advancements, and increasing adoption of minimally invasive procedures.

Who are the major players in this market?

Key players include Medtronic, Terumo Corporation, Boston Scientific Inc., Stryker, Biotronik, Cook, and B. Braun.

Which region commanded the largest share of the Peripheral Vascular Stents Market in 2024?

North America led the market in 2024, holding approximately 30% of the global share.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Food Allergy Diagnosis Treatment Market

Food Allergy Diagnosis Treatment market size was valued at USD 1.72 billion in 2024 and is anticipated to reach USD 3.13 billion by 2032, at a CAGR of 7.8% during the forecast period.

Duodenoscopes Market

Duodenoscopes Market size was valued USD 470.5 million in 2024 and is anticipated to reach USD 711.19 million by 2032, at a CAGR of 5.3% during the forecast period.

Rosacea Treatment Market

The Rosacea Treatment Market was valued at USD 2.48 billion in 2024 and is projected to reach USD 4.04 billion by 2032, growing at a CAGR of 6.3 % during the forecast period.

Handheld Retinal Scanners Market

Global Handheld Retinal Scanners Market size was valued at USD 732.3 Million in 2018, growing to USD 980.8 Million in 2024, and is anticipated to reach USD 1,480.4 Million by 2032, at a CAGR of 5.31% during the forecast period.

Hand Hygiene Compliance Monitoring Systems Market

The Global Hand Hygiene Compliance Monitoring Systems Market size was valued at USD 4,651.4 million in 2018, increasing to USD 6,606.9 million in 2024, and is anticipated to reach USD 11,198.6 million by 2032, growing at a CAGR of 6.89% during the forecast period

Endodontics And Orthodontics Market

The Global Endodontics and Orthodontics Market size was valued at USD 5,689.2 million in 2018, increased to USD 8,752.3 million in 2024, and is anticipated to reach USD 16,669.8 million by 2032, growing at a CAGR of 8.47% during the forecast period.

Breast Prosthesis Market

The Global Breast Prosthesis Market size was valued at USD 967.6 million in 2018, reaching USD 1,295.8 million in 2024, and is anticipated to attain USD 1,955.9 million by 2032, growing at a CAGR of 5.31% during the forecast period.

Cranial Fixation and Stabilization Market

The global cranial fixation and stabilization market was valued at USD 2.42 billion in 2024 and is projected to reach USD 3.83 billion by 2032, growing at a CAGR of 5.9% during the forecast period.

Forensic Imaging Market

Forensic imaging market size was valued USD 87.95 million in 2024 and is anticipated to reach USD 176.53 million by 2032, at a CAGR of 10% during the forecast period.

Cranial Stabilization Devices Market

Cranial Stabilization Devices Market size was valued USD 675 million in 2024 and is anticipated to reach USD 952.59 million by 2032, at a CAGR of 4.4% during the forecast period.

Sleep Apnea Devices Market

The Sleep Apnea Devices Market size was valued at USD 8.82 billion in 2024 and is anticipated to reach USD 18.78 billion by 2032, at a CAGR of 9.9% during the forecast period.

Medical Heat Sealers Market

The Medical Heat Sealers Market size was valued at USD 2,050.00 million in 2018, reached USD 2,639.14 million in 2024, and is anticipated to reach USD 4,637.23 million by 2032, at a CAGR of 7.37% during the forecast period.

Licence Option

Single User

$4999

Multi User

$6999

Enterprise

$12999

Report delivery within 24 to 48 hours

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Request A Free Sample

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample